XSHE
002274
Market cap835mUSD
Oct 09, Last price
5.91CNY
1D
0.68%
1Q
2.60%
Jan 2017
-2.15%
IPO
3.70%
Name
Jiangsu Huachang Chemical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Huachang Chemical Co., Ltd manufactures and sells agrochemicals, basic chemicals, fine chemicals, and biochemical products in China. It offers chemical products, such as industrial methanol, ammonium chloride, urea, sodium carbonate, anhydrous ammonia, nitric acid, and medicinal urea; and new material products, including n-butyraldehyde, isobutyraldehyde, n-butyl and isooctyl alcohol, propane, neopentylglycol, and polyester resin. It also offers potassium fulvic acid and marine algae loss control, flower, cash crop, urea ammonium nitrogen, bio-organic, stable, and specialized fertilizers. The company also produces and sells ecological fertilizers, and provision of new material technology development and waste management services. Jiangsu Huachang Chemical Co., Ltd was founded in 1970 and is headquartered in Zhangjiagang, China.
Key people
Yujian Zhu
Vice Chairman of the Board · since 2022
Huifen Zhao
Chief Financial Officer, Director · since 2016
Changsheng Li
Deputy General Manager · since 2019
Aidong Tan
Deputy General Manager · since 2017
Ruyi Zhou
Deputy General Manager · since 2004
Xiaowei He
Deputy General Manager, Director · since 2016
Bo Hu
Chairman of the Board · since 2022
Long Lu
Secretary of the Board, Director · since 2016
Binbin Xu
Director · since 2025
Hanqing Zhang
General Manager, Director · since 2025
Independent Director · since 2023
Li Li
Independent Director · since 2022
Independent Director · since 2024
Headquarters & legal address
张家港市金港镇保税区扬子江国际化学工业园南海路1号
苏州市, JS 100000
CN
苏州市, JS 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||